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Abstract
Background: Depression is a leading contributor to disability-adjusted life-years because of early onset and
chronicity throughout the lifecycle. It is crucial to identify early predictors of depression among adolescents
and young people to effectively target prevention. A gap in the literature is a comprehensive systematic
review of predictors of depression among adolescents around the globe, especially in low- and middle-
income countries LMICs. This review aims to identify evidence for biological, psychological, and contextual
risk factors for the development of depression among adolescents and young adults (10–24 years of age) in
high-income countries (HICs) and LMICs, ultimately contributing to (a) identification of potential
mechanisms underlying depression development, (b) selection of common risk and protective factors as
targets for detection, and (c) refinement of risk models that can be evaluated through existing cohorts in
HICs and LMICs.
Methods: This review will follow the Population, Exposure, Comparison, Outcome (PI(E)CO) model and
adheres to the PRISMA-P guidelines. A search strategy was developed by a multidisciplinary research
consortium. Seven databases (MEDLINE via Ovid, PsycINFO, Cochrane Database of Systematic Reviews, Web
of Science, Lilacs, African Journals Online, Global Health) will be searched to identify articles. Independent
raters will screen and retrieve articles for inclusion, conduct quality ratings, and extract data. The Systematic
Assessment of Quality in Observational Research adapted for Cultural Psychiatry Epidemiology (SAQOR-CPE)
will be used to assess quality of observational studies. We will assess for publication bias using funnel plots
and statistical methods. We will use narrative synthesis to present results, addressing the study’s objectives
following the Cochrane Handbook guidelines. Meta-analyses will be used to report summary statistics for
association of risk factors with development of depression.
Discussion: This systematic review will summarize evidence-based research that examines the psychological,
biological, and contextual factors contributing to the onset of depression in adolescents across the globe.
Results will support the development of a model that can be evaluated in existing cohorts around the world.
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Background
The onset for most mental illnesses is during adoles-
cence and early adulthood [1, 2]. This burden of
adolescent mental illness is disproportionately borne
by young people in low- and middle-income coun-
tries (LMICs) who comprise nearly 90% of the
world’s youth and who have the least access to ser-
vices [3–6]. Moreover, one out of three suicides
worldwide occurs among adolescents in LMICs [7].
Among mental illnesses, depression is the leading
contributor to disability-adjusted life years—in part
because of early-onset and chronicity throughout the
lifecycle [8]. Therefore, there is a crucial public
health need to identify early predictors of depression
among adolescents and young people, with special
attention to LMICs given the greatest burden and
least research in these settings [4]. One key gap in
the literature is a systematic review of the predictors
of depression among adolescents and young people
focusing on the global literature. Therefore, this sys-
tematic review will focus on early-life risk and pro-
tective factors for depression including studies from
both high-income countries (HICs) and LMICs.
Previous reviews have been conducted on risk fac-
tors for adolescent depression, although currently,
the reviews are focused on specific risk factors and
overall generalizability of the evidence is limited,
with most reviews only able to report on HICs. For
example, Kohler and colleagues conducted an um-
brella review mapping risk factors for depression
over the lifespan, but with a focus on only environ-
mental factors [9]. Cairns et al. [10] conducted a
systematic review on risk and protective factors for
adolescent depression, but, focusing only on modifi-
able factors, the review was not able to address con-
textual factors such as those at the community or
family level. In the same review, of the 113 included
studies, 97% of them reported on populations from
HICs, a trend found in similar reviews [11, 12].
Moreover, when considering a global perspective on
the development of depression, it is important to
consider a wider range for the age group of interest
(e.g., youth under the age of 25 years old) to account
for variance in contextual factors that may play a role in
the development of the adolescent brain [13, 14],
particularly in LMICs. Currently, of the 12
adolescent systematic reviews found relevant to this
review’s topic, only 1 included ages 25 and under
[15]; all others included ages 19 years or younger
[10–12, 16–24].
Upon completion of this systematic review, we
hope to address the above gaps in the literature, as
well as contribute to the following endeavors:
– Identify common risk and protective factors
across global studies as potential mechanisms
underlying the development of depression in
adolescence;
– Identify common risk factors as potential targets
for early detection and interventions;
– Identify regional and other potential population-
specific variation in risk pathways for depression
among adolescents as contextual modifiers for
the focus of research and intervention
adaptation;
– Identify common risk and protective factors to
refine predictive models that can be evaluated using
existing cohorts in HICs as well as in LMICs.
Objectives
The primary objective of this review is to identify the
evidence for biological, psychological, and contextual
risk factors for the development of depression among
adolescents (25 years and younger) in HICs and LMICs.
The secondary objectives are to identify the evidence for
risk and protective factors specifically found within pro-
spective longitudinal observational studies in HICs and
LMICs, to identify the evidence for risk and protective
factors specifically found within cross-sectional studies
conducted in LMICs, and to identify the evidence for a
relationship of biological and contextual risk factors with
depression in adolescents in HICs and LMICs.
Methods
This protocol was developed in accordance with the
Preferred Reporting Items for Systematic Review and
Meta-Analysis Protocols (PRISMA-P) 2015 checklist [25].
This protocol has been registered in the International Pro-
spective Register of Systematic Reviews (PROSPERO),
study protocol registration CRD42018103973.
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Operationalization of key constructs
Adolescence
The World Health Organization (WHO) recognizes
persons aged 10–19 as adolescents and those aged
15–24 as youth, with a comprehensive category of
young people referring to ages 10–24 years [13]. Per-
sons between the ages of 10–24 may be defined as
adolescents as it is noted that youth changes with
circumstances, especially when considering changes
in settings demographically, financially, economically,
and socio-culturally [14]. Therefore, for the purposes of
this review, we will follow the WHO categorization of
young people as 10–24 years of age, which is inclusive of
adolescence [26].
Biomarker
We operationalize biomarker as “a biological charac-
teristic objectively measured and evaluated for indica-
tions of normal biological or pathological processes,
or a response to a therapeutic intervention” [27].
Depression
Usually defined as a common mental disorder,
depression is characterized by persistent sadness (or
irritability in the case of adolescents) and a loss of
interest in activities, accompanied by an inability to
carry out daily activities. Symptoms range from mild
to moderate and may include (but are not limited
to) several of the following: loss of energy, change in
appetite, anxiety, restlessness, feelings of worthless-
ness, guilt, hopelessness, indecisiveness, sleeping
more or less, or thoughts of self-harm or suicide.
Depression is globally experienced on a continuum
[28, 29] and for the purposes of this review will be
defined by clinical diagnoses, structured clinical in-
terviews, self-report rating scales, or medical records.
The supplemental file includes a list of diagnoses
and associated codes meeting the criteria for inclu-
sion for the Diagnostic and Statistical Manual of
Mental Disorders and International Classification of
Disease (see Additional file 1).
Low- and middle-income countries
Low-income economies are $1025 or less gross na-
tional income (GNI) per capita in 2015; lower mid-
dle-income economies are those with a GNI per
capita between $1026 and $4035; upper middle-in-
come economies are those with a GNI per capita be-
tween $4036 and $12,475; and high-income
economies are those with a GNI per capita of $12,
476 or more (https://blogs.worldbank.org/opendata/
new-country-classifications-2016). For countries that
have changed economic status during the period of
longitudinal data collection, we will require that the
country met the World Bank criteria for an LMIC
lending category at the time of initiating the cohort.
Mechanisms of action/mechanisms of change
This review will use the National Institute of Mental
Health (NIMH) definition of mechanism of action as
a “target of engagement” which may create the
potential for development (“go” outcome) or reject
this potential (“no-go” outcome) and its ability to
modify disease, behavior, or functional outcomes; in
other words, it is the basis for the effect and may
also be the process or steps responsible for a thera-
peutic outcome [30–32].
Mediators and moderators
A mediator is operationalized as an intervening vari-
able which lies on the causal pathway between the
exposure and outcome; it may provide additional in-
formation as to how a change or outcome came
about, but it is not necessarily a mechanism for
change [30, 33]. A moderator is operationalized as a
characteristic that influences the direction or magni-
tude of the relationship between an independent and
dependent variable [30].
Protective and risk factors
Using Cairns and colleagues’ definitions (p. 63), we
will operationalize a protective factor as “an ante-
cedent condition associated with a decrease in the
likelihood of the outcome of interest” [10, 34] and a
risk factor as “an antecedent condition associated
with an increase in the likelihood of the outcome of
interest” [10, 34].
Study eligibility criteria
Types of studies
For the initial search of risk and protective factors
for depression in adolescence in HICs and LMICs,
studies using longitudinal prospective designs will be
identified. A second search will focus specifically on
LMICs to examine cross-sectional study designs due
to the lack of longitudinal studies evidenced in these
settings. Finally, when considering the relationship
between biological, psychological, and contextual fac-
tors and adolescent depression, we will include lon-
gitudinal and cross-sectional studies and intervention
and prevention trials in order to capture any bio-
logical or contextual factors that may be evidenced
while considering the gap in longitudinal study de-
signs conducted in LMICs. Trials or experimental
designs will only be included when examining bio-
logical factors in order to expand the pool of poten-
tial studies. Discussion papers, letters, editorials, case
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studies or case series, and qualitative studies without
a quantitative element will be excluded.
Type of participants and settings
Both sexes in adolescent populations will be in-
cluded in this review. Included studies will require a
depression outcome (as defined by a categorical
DSM/ICD diagnosis, clinical diagnosis, medical re-
cords, structured interview, or self-report measure).
Eligible populations will be young people in high-,
middle-, and low-income countries who are under
the age of 25 years at study baseline and have been
evaluated for depression with at least one
subsequent time point of at least 6 months. The
LMIC-specific analysis will also include young people
living in LMICs who are under the age of 25 years
who have been evaluated for the presence of depres-
sion or depressive symptoms. The biological factors’
objective will include adolescents in high-, middle-,
and low-income countries who are under the age of
25 years and were evaluated for depression and for
biological markers of interest, as well as psycho-
logical or contextual markers associated with
depression. Given the high rates of psychiatric co-
morbidity, populations with depression plus other
psychiatric conditions (including substance abuse)
will be included for the risk and protecte factors
part of the review. Studies limited only to specific
medical subpopulations (e.g., only young people with
HIV, diabetes, intellectual disabilities) that do not in-
clude comparative populations will be excluded. Any
longitudinal studies with an initial prospective time
point of under 6 months will also be excluded. Medi-
cation or other treatment status will not be an ex-
clusion criterion, but information will be reported
on these whenever available.
Type of exposures
The following factors will be evaluated for association
with depression among young people:
– Contextual factors associated with an increased
risk for developing major depression during
adolescence (this review will include
demographic, economic, family, neighborhood,
environmental, and social and cultural factors; in
addition, we will explore life events and
traumatic exposures);
– Biological markers associated with an increased
risk for developing major depression during
adolescence. This review will focus on studies
that address the following: hypothalamic-
pituitary-adrenal axis (HPA axis), inflammation,
endocannabinoids, vitamins, polyunsaturated fatty
acids (PUFAs), hormones, neurotrophic factor,
neurotransmitters, telomere/gene length,
neuroplasticity, and gene expression (including
mRNA quantification);
– Brain-related abnormalities in individuals at risk
for major depression during adolescence (this
review will focus on magnetic resonance imaging
studies, both structural and functional, assessing
children/adolescents at risk);
– Psychological factors associated with increased or
decreased risk for developing major depression
during adolescence (this review will include
factors such as self-esteem, locus of control,
cognitive biases, emotional regulation, reward
responsivity, and learned helplessness).
Comparators
Comparison groups will vary between objectives (see
Appendix 1) but will broadly include adolescents
who are not exposed to the factor of interest prior
to the time of assessment or adolescents who do not
develop depression during the assessed periods of
adolescence and young adult development.
Outcomes
The primary outcome will be development of de-
pression among young people with a cutoff of 25
years of age or younger and also allowing for studies
that include earlier endpoints of depression develop-
ment, in any population, i.e., high-, middle-, and
low-income countries. The primary outcome mea-
sures of depression may include self-reports, adult-
informant reports, structured observations in clinical
settings, and clinical records.
Timing of outcome assessment
Eligible studies should include assessment of depres-
sion during at least one time period between the
ages of 10 and 24 years and a follow-up time point
at least 6 months later.
Search strategy for identifying relevant studies
We will search the following electronic databases to
identify potentially relevant studies for our review:
MEDLINE (via Ovid), PsycINFO, Cochrane Database
of Systematic Reviews, Web of Science (Core Collec-
tion), Lilacs, African Journals Online, and Global
Health. In addition to these electronic databases, we
also plan to identify relevant studies by reviewing
reference lists of eligible studies and review articles
and by contacting experts and authors of eligible
studies by email. Relevant systematic reviews from
the database outputs will be hand-searched for any
eligible studies which may have been missed. Only
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published research in academic journals will be used
for objectives 1 and 3 of this review (see below).
Searches will be conducted in English, though publi-
cation language will not be a limiter. The Boolean
operator “OR” will be used to find articles with one
or more search terms and synonyms and “AND” to
combine the different concepts for relevant articles.
Where applicable, MeSH subheadings will be used,
and “keywords” where relevant for given databases.
For objective 2 (see below), which will use data from
LMIC, we will expand our search to grey literature.
Some studies of adolescents in LMIC are presented
in reports of nongovernmental organizations, and
these findings may not be reported in the academic
literature. Therefore, we will review reports from
international and national nongovernmental organi-
zations and will attempt to identify additional litera-
ture through listservs used by mental health
psychosocial practitioners working in nongovernmen-
tal organizations.
We will use truncation and wildcards to account
for UK and US spelling and terminology and abbre-
viation. The concept combinations will vary with
objective (see Appendix 1), but the three main con-
cepts combined will include Population AND Expos-
ure AND Outcome, for example, adolescence AND
risk/protective factors AND depression. Years of
publication will not be used to limit the search out-
put, but extraction will begin in descending chrono-
logical order, assessed at the first 10 years for
sufficient robust evidence, then proceed to the next
10 years or more if deemed necessary to capture rep-
resentative data.
Searches will be re-run before the date of final
analyses to identify recent publications in the field.
Objective 1—identify risk and protective factors as-
sociated with the development of depression among
adolescents and young people in populations evalu-
ated for at least 6 months (i.e., longitudinal samples).
Sample MEDLINE (Ovid) search:
Adolescent/ OR “adolesc*” AND Depression/ OR
Depressive disorder/ AND Longitudinal Studies/ OR
“longitudinal”
Objective 2—identify risk and protective factors as-
sociated with depression among adolescents and
young people in LMICs.
Sample MEDLINE (Ovid) search:
Adolescent/ OR “adolesc*” AND Depression/ OR De-
pressive disorder/ AND Developing Countries/ OR “de-
veloping countr*” OR World Bank List (as keywords)
Objective 3—identify risk and protective factors as-
sociated with biological markers, brain related
abnormalities, and context among adolescents and
young people.
Sample MEDLINE (Ovid) search:
Adolescent/ OR “adolesc*” AND Depression/ OR De-
pressive disorder/ AND “HPA axis” OR Pituitary-Adrenal
System
See Appendix 1 for full MEDLINE search, Objective 1.
Data collection
Selection of studies
A charting form will be used to identify studies to be in-
cluded in the review according to the inclusion and ex-
clusion criteria. Two review authors will independently
review titles and abstracts of studies identified through
the search strategy and those from additional resources
(e.g., contacting authors and searching reference lists of
included papers, which will be done through hand
searches, Web of Science citation records, or Scopus
when appropriate) to determine whether studies poten-
tially meet the inclusion criteria. To assess for study eli-
gibility, two reviewers will independently review the full
publication texts of studies identified through title and
abstract review. They will record justification for exclu-
sion for each excluded study. A third author will resolve
disagreements between the two reviewers.
Retrieval of studies
The full text of the selected articles will be retrieved.
When a full article is not available through the database
or university library services, it will be searched through
ResearchGate and Google Scholar, or a request to share
the full article will be sent by email to the corresponding
author. After the request has been sent, a reminder will
be sent after a week. If there is no response within
2 weeks from the reminder, this document will be ex-
cluded from the systematic review.
Data extraction and management/coding
Extraction fields will include, but not be limited to,
article information (publication year, journal), study
characteristics (country, urban vs. rural setting, fund-
ing), population characteristics (age at enrolment,
current age, number of longitudinal assessments), de-
pression assessment (depression criteria, duration of
depression, assessment tool, co-morbidity), risk factors
(poverty, trauma, family history), protective factors
(education, social capital), assessment tool (instrument
names and psychometric properties for depression,
risk, and protective factors), and biological variables
(interleukins, cortisol, galvanic skin response, neuro-
imaging). Two authors will independently extract data
from the published reports of included studies using a
standardized, electronic form (e.g., in Microsoft
Excel), which will be developed and pre-piloted to as-
sure interrater agreement. We will attempt to collect
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missing information by contacting the corresponding
authors via email.
Assessment of risk of bias in included studies
Two reviewers will independently assess the risk of bias
in included studies by evaluating the following domains:
– Recruitment and sampling strategy
– Follow-up strategy, retention, and selective attrition
– Completeness of outcome data
– Validity and other psychometrics of depression
outcomes and other tools used
– Selective outcome reporting
– Other sources of bias related to context, procedures,
and reporting
We will assess the quality of observational studies using
the Systematic Assessment of Quality in Observational
Research (SAQOR) [35] and the adapted SAQOR Cultural
Psychiatry Epidemiology (SAQOR-CPE) [36]. If any inter-
vention studies are included, we will limit the analyses to
be pre-treatment findings or control groups. We will apply
the SAQOR-CPE to the samples of interest in the inter-
vention studies. Quality level will be recorded as high,
moderate, low, or very low risk of bias for each domain,
and bias rating will be compared between the two author
reviewers. A third author will resolve discrepancies. Emails
to authors will be used to obtain additional information to
reduce sources of bias and adjust risk.
Data analysis
Measurement of exposure effect
The primary comparison for this systematic review will
be development of depression before the age of 25 years
old. We anticipate that there will be substantial hetero-
geneity between studies (including reporting differences)
that may limit our ability to conduct quantitative synthe-
ses of findings. Similarly, we anticipate heterogeneity in
measurement of depression and depressive symptoms,
as well as validation, evaluation, and translation of tools.
Where there is adequate homogeneity, we will synthesize
results using random-effects meta-analysis. We will use
standardized mean differences (SMDs) for continuous
outcomes and risk ratios for binary outcomes and calcu-
late 95% confidence intervals and two-sided p values for
each outcome. When applicable, we will use SMDs to
generate pooled estimates to compare different types of
risk factors. We will conduct all quantitative tests using
appropriate techniques in Stata, R, and in Comprehen-
sive Meta-Analysis (Biostat, Englewood, NJ, https://
www.meta-analysis.com/). We will follow Ioannidis and
colleagues [37] recommendations for conducting meta-
analyses and reporting summary statistics. Rather than a
priori excluding use of meta-analysis or setting specific
criteria for degree of heterogeneity, Ioannidis and
colleagues state that it is preferable to present the sum-
mary statistic, while clearly documenting the heterogen-
eity and its possible causes. We employ methods
recommended by Ioannidis and colleagues to report
and adjust for heterogeneity.
Unit of analysis issues
The study population will be the unit of analysis. We do
not anticipate obtaining sufficient access to individual-
level data to conduct individual-level analyses. Studies that
only include cluster-level analysis will not be included.
Dealing with missing data
For missing measures of precision (confidence inter-
vals or standard deviations) that remain unavailable
after attempting to contact study authors, we will as-
sume the highest variability observed within the
group of studies being analyzed.
Assessment of reporting bias
We will assess for publication bias using funnel plots. In
addition, we will use the approach outlined by Begg and
Mazumdar [38] to statistically test for publication bias.
Data synthesis
We will provide a narrative synthesis of findings from
the included studies. Following Cochrane guidelines
[39], we will provide narrative synthesis information sep-
arately by study type. From the studies, we develop a
conceptual framework to identify themes. This will be
done at the full-text stage after reviewing the manu-
scripts. We will provide descriptives, compare studies on
characteristics, tabulate results to identify patterns
across studies, use vote counting, and translate data for
thematic and content analyses per Cochrane recommen-
dations. For quantitative synthesis, we will provide sum-
maries of the primary outcome measures for each study.
We will include forest plots summarizing results of indi-
vidual studies and the meta-analyses. Summaries of de-
pression outcomes will be subcategorized accordingly by
self-report, parent or teacher report, clinical instrument,
or healthcare service diagnosis. Also, specifically for the
biological factors, summaries will be stratified by those
with and without substance abuse diagnoses. We will
run meta-analyses for each objective with meta-regres-
sion where appropriate, as well as assess methodological
issues and conduct sensitivity analyses.
Subgroup analysis and assessment of heterogeneity
If possible, we will conduct subgroup analyses based on
HICs vs. LMICs, by age of onset, co-morbidities, outcome
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type (e.g., self-report, clinical interview, medical records),
geographic region, and population settings (primary care,
non-psychiatric specialty services, communities, religious
centers, schools). Some included studies may report onset
of depression after 25 years of age for some participants.
Therefore, we will potentially conduct subgroup analyses
by age group of onset: those who have developed depres-
sion before the age of 25 and those who have developed it
after the age of 25 for studies that follow participants into
adulthood. Subgroup analyses will be conducted in Com-
prehensive Meta-Analysis, including analysis of statistical
difference among subgroups. We will assess heterogeneity
using the chi-squared test, I-squared statistic, and predic-
tion interval [40]. We will evaluate for potential sources of
heterogeneity. We will address heterogeneity by using ran-
dom-effects meta-analysis models and sensitivity analyses.
We will use the approach of referring to “low, moderate,
and high” heterogeneity at the I2 thresholds of 25%, 50%,
and 75%, with the caveat that quantification of heterogen-
eity will be considered only one marker of variability across
studies [41] and the concerns raised by Cuijpers [42] that
even point estimates of I2 may have wide confidence inter-
vals extending into the ranges of high heterogeneity.
Sensitivity analysis
We will conduct sensitivity analyses as recommended by
the Cochrane Handbook (Section 9.7) [43]. For example,
sensitivity analyses will be conducted removing the stud-
ies with the strongest effects sizes and studies with the
largest sample sizes. We will follow the approach de-
scribed in Patsopoulos et al. [44] of excluding up to two
studies to see if heterogeneity crosses the threshold
below 50% or 25%.
Assessing overall confidence in cumulative evidence
We will use the Confidence in the Evidence from Re-
views of Qualitative research (CERQual) tool to assess
confidence in the qualitative syntheses. Similarly, we will
use SAQOR-CPE in reference to quantitative reviews.
Presentation of results
We will present the results of our systematic review
through a narrative description addressing the study’s
objectives and through charts and tables as recom-
mended in the Cochrane Handbook (Section 11) [43].
First, we will tabulate data from our search process into
a flowchart indicating the number of studies identified
and excluded at key steps, according to the PRISMA
guidelines [25]. Second, we will summarize information
on individual studies in a “Characteristics of Included
Studies” table. Third, we will present “Data and Ana-
lyses” tables and forest plots to present outcome data
from individual studies and from any meta-analyses.
Fourth, we will present a “Summary of Findings” table to
summarize key data available, magnitude of effect of the
risk and protective factors studied, and quality of evi-
dence addressing the key study objectives.
Discussion
There is a crucial public health need to identify early
predictors of depression among adolescents and young
people around the globe, with special attention to
LMICs given that the greatest burden and least research
is found in these settings. This systematic review aims to
address gaps in the review literature and will summarize
evidence-based research which looks at the psycho-
logical, biological, and contextual factors contributing to
the onset of depression in adolescents and young people
across the globe. Recommendations will be made to in-
form future research priorities. The results will support
the exploration of the feasibility and acceptability of
early detection and interventions in LMICs and support
the development of a common risk factor assessment
model that can be evaluated using existing cohorts in
HICs as well as in LMICs. These results will inform rele-
vant academic and practitioner communities, key stake-
holders such as policy- and decision-makers, and
adolescents and their families.
Appendix 1
Table 1 MEDLINE (Ovid) search, objective 1
1. ADOLESCENT/
2. (adolesc* or "youth" or "teen" or "young people" or "young
person*").mp. [mp=title, abstract, original title, name of substance
word, subject heading word, floating sub-heading word, keyword
heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier, synonyms]
3. Young Adult/
4. 1 or 2 or 3
5. DEPRESSION/
6. Depressive Disorder/
7. Depressive Disorder, Major/
8. ("depressive disorder" or "symptoms of depression" or "major
depressive disorder").mp. [mp=title, abstract, original title, name of
substance word, subject heading word, floating sub-heading word,
keyword heading word, protocol supplementary concept word, rare
disease supplementary concept word, unique identifier, synonyms]
9. 5 or 6 or 7 or 8
10. LONGITUDINAL STUDIES/
11. Prospective Studies/
12. Observational Study/
13. (longitudinal or prospective or "observational stud*").mp. [mp=title,
abstract, original title, name of substance word, subject heading
word, floating sub-heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
14. 10 or 11 or 12 or 13
15. 4 and 9 and 14
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Additional file
Additional file 1: List of diagnoses and associated codes meeting the
criteria for inclusion for the Diagnostic and Statistical Manual of Mental
Disorders and International Classification of Disease. (DOCX 12 kb)
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